Navigating the Whirlwind Surrounding N-Nitrosamine Impurities in APIs and Drug Products
October 1, 2025
FDA Practice Group Leader David Rosen is speaking in SAAMnow’s Fall Workshop in the session “Navigating the Whirlwind Surrounding N-Nitrosamine Impurities in APIs and Drug Products” on October 1.
The workshop will focus on regulatory, scientific, and technical challenges surrounding the presence of N-nitrosamine impurities in active pharmaceutical ingredients (APIs) and drug products. Participants will explore cutting-edge methods, regulatory updates, and research developments regarding N-nitrosamines.
The workshop will address:
- U.S. Food and Drug Administration (FDA) perspective on N-Nitrosamine Impurities,
- International Generic and Biosimilar Medicines Association (IGBA) perspective on nitrosamine impurities, the worldwide challenges,
- ICH M7 risk assessment and control of N-nitrosamine impurities,
- Over-the counter (OTC) drug products and their challenges with N-nitrosamine impurities, and
- Prescription drug products and their challenges with N-Nitrosamine impurities.
People
Related Insights
January 14, 2026
Health Care Law Today
Protecting the AI Advantage: Why Patents Are a Critical Growth and Risk-Management Tool for Digital Health Platforms
For CEOs, general counsels, and CTOs, the question is no longer whether patents matter. The question is whether the company has an…
February 23, 2026
Events
International Consumer Products Health and Safety Organizaton 2026 Annual Meeting and Training Symposium
On February 23-26, the International Consumer Products Health and Safety Organization (ICPHSO) will host its 33rd Annual Meeting and Training Symposium in Orlando, Florida. This flagship event brings together global product safety professionals for four days of collaboration, learning, and networking.
February 18, 2026
Events
2026 CPG Legal Forum
On February 19, Foley partners Erik Swanholt and Kate Wegrzyn will speak at the Consumer Brands CPG Legal Forum in Frisco, Texas. Swanholt, chair of the firm’s Consumer Products Team, will serve on the panel “Take Cover from Risky Business: Insurance Considerations for Mass Tort, Class Action, Supply Chain Disruption and Recalls.” Wegrzyn, chair of Foley’s Supply Chain Team, will participate in the panel “Tariff-ied Yet? Untangling Legal Links in the Supply Chain from Ports to Courts.”